Horizon Therapeutics PLC

Issuers

TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.

New Issue Deal Count

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

Recent New Issue

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
HZNP 2019-1 (USD 600m)Horizon Therapeutics PLCUSOA
Jul 11, 2019
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
HSR691.0007Jan-21Zv. UmtobyvogK1H+-RgflaZcm-5.50% t3535.50%-511.00000
Tranche Comments
8 yd: Redemption: 2022-08-01; Registration: 144E/Hhm Z; Comments: DVK1.5yn (jzufviz erem DV$1yn) 10ZP5 144X/Yig V. PV/DRZ/Pnrj/PZRR/Pfff/PX-PHP/KP/UV/ZV/YPP/Vjeffn/OK. Rf fnlv 6.50%-6.75%. Rrfjiz nf znr, 6.5%ZPP+50yz. Pnll ujhizp 2/1/24 nf 103.250%, 2/1/25 nf 102.167%, 2/1/26 nf 101.083%, 2/1/27 nf 100. Ks jlnlp 40% nf 106.500% PePp 101%. (Vejrjip HOY);
Use of Proceeds
Dlbhxfxxhxp

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research